Naturally Splendid (TSXV:NSP), through their South Korean master distributor Korea Beauty & Healthcare Co., Ltd., launched Naturally Splendid hemp foods through the Lotte Home Shopping Channel in South Korea under the brand Paleo/NATERA.
Watch the full video:
Connect with Naturally Splendid (TSXV:NSP) to receive an Investor Presentation.
Canopy Growth to Report Third Quarter Fiscal 2021 Financial Results on February 9, 2021
January 26 | 2021
Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) will release its financial results for the third quarter fiscal 2021 ended December 31, 2020 before financial markets open on February 9, 2021.
</div>
<p> Following the release of its third quarter fiscal 2021 financial results, Canopy Growth will host an audio webcast with <span> David Klein </span> , CEO and <span> Mike Lee </span> , EVP & CFO at <span> 10:00 AM Eastern Time </span> on February 9, 2021. </p>
<p> <b> Webcast Information <br/></b> A live audio webcast will be available at: <br/><u> <a href="https://c212.net/c/link/?t=0&l=en&o=3047675-1&h=4020497659&u=https%3A%2F%2Fproduceredition.webcasts.com%2Fstarthere.jsp%3Fei%3D1418491%26tp_key%3D44498b6183&a=https%3A%2F%2Fproduceredition.webcasts.com%2Fstarthere.jsp%3Fei%3D1418491%26tp_key%3D44498b6183" rel="nofollow noopener noreferrer" target="_blank"> https://produceredition.webcasts.com/starthere.jsp?ei=1418491&tp_key=44498b6183 </a> </u> </p>
<p> <b> Replay Information <br/></b> A replay will be accessible by webcast until <span> 11:59 PM ET </span> on <span> May 10, 2021 </span> at: <br/><u> <a href="https://c212.net/c/link/?t=0&l=en&o=3047675-1&h=4020497659&u=https%3A%2F%2Fproduceredition.webcasts.com%2Fstarthere.jsp%3Fei%3D1418491%26tp_key%3D44498b6183&a=https%3A%2F%2Fproduceredition.webcasts.com%2Fstarthere.jsp%3Fei%3D1418491%26tp_key%3D44498b6183" rel="nofollow noopener noreferrer" target="_blank"> https://produceredition.webcasts.com/starthere.jsp?ei=1418491&tp_key=44498b6183 </a> </u> </p>
<p> <b> About Canopy Growth Corporation <br/></b> Canopy Growth (TSX:WEED,NASDAQ:CGC) is a world-leading diversified cannabis and cannabinoid-based consumer product company, driven by a passion to improve lives, end prohibition, and strengthen communities by unleashing the full potential of cannabis. Leveraging consumer insights and innovation, we offer product varieties in high quality dried flower, oil, softgel capsule, infused beverage, edible, and topical formats, as well as vaporizer devices by Canopy Growth and industry-leader Storz & Bickel. Our global medical brand, Spectrum Therapeutics, sells a range of full-spectrum products using its colour-coded classification system and is a market leader in both <span> Canada </span> and <span> Germany </span> . Through our award-winning Tweed and Tokyo Smoke banners, we reach our adult-use consumers and have built a loyal following by focusing on top quality products and meaningful customer relationships. Canopy Growth has entered into the health and wellness consumer space in key markets including <span> Canada </span> , <span> the United States </span> , and <span> Europe </span> through BioSteel sports nutrition, and This Works skin and sleep solutions; and has introduced additional federally-permissible CBD products to <span> the United States </span> through our First & Free and Martha Stewart CBD brands. Canopy Growth has an established partnership with Fortune 500 alcohol leader Constellation Brands. For more information visit <a href="https://c212.net/c/link/?t=0&l=en&o=3047675-1&h=3399213254&u=https%3A%2F%2Fwww.canopygrowth.com%2F&a=www.canopygrowth.com" rel="nofollow noopener noreferrer" target="_blank"> www.canopygrowth.com </a> . </p>
<div id="DivAssetPlaceHolder2"> </div>
<p id="PURL"> <img alt="Cision" class="lazy" data-src="https://c212.net/c/img/favicon.png?sn=OT59378&sd=2021-01-26" data-srcset="" height="12" src="https://c212.net/c/img/favicon.png?sn=OT59378&sd=2021-01-26" srcset="" title="Cision" width="12"/> View original content to download multimedia: <a href="http://www.prnewswire.com/news-releases/canopy-growth-to-report-third-quarter-fiscal-2021-financial-results-on-february-9-2021-301215453.html" id="PRNURL" rel="nofollow noopener noreferrer" target="_blank"> http://www.prnewswire.com/news-releases/canopy-growth-to-report-third-quarter-fiscal-2021-financial-results-on-february-9-2021-301215453.html </a> </p>
<p> SOURCE Canopy Growth Corporation </p>
<p> <img alt="" class="lazy" data-src="https://rt.newswire.ca/rt.gif?NewsItemId=C2849&Transmission_Id=202101261615CANADANWCANADAPR_C2849&DateId=20210126" data-srcset="" src="https://rt.newswire.ca/rt.gif?NewsItemId=C2849&Transmission_Id=202101261615CANADANWCANADAPR_C2849&DateId=20210126" srcset=""/></p>
<p> <img alt="Cision" class="lazy" data-src="https://c212.net/c/img/favicon.png?sn=C2849&sd=2021-01-26" data-srcset="" height="12" src="https://c212.net/c/img/favicon.png?sn=C2849&sd=2021-01-26" srcset="" title="Cision" width="12"/> View original content to download multimedia: <a href="http://www.newswire.ca/en/releases/archive/January2021/26/c2849.html" rel="noopener noreferrer" target="_blank"> http://www.newswire.ca/en/releases/archive/January2021/26/c2849.html </a> </p>
</div>
</div>
<p>News Provided by Canada Newswire via QuoteMedia</p>
<p></p><div class="cp-text-ad"><div class="row text-ad-ofie">
<div class="ad-image large-4 medium-4 small-12 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<img alt="Cannabis Free Report Cover" class="hide-for-small-only" src="https://cdn.investingnews.com/app/uploads/2020/05/Profiting-from-Cannabis-Industry-3D.jpg" title="Profiting from the Cannabis Industry"/></a></div>
<div class="ad-copy large-8 medium-8 small-11 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<h2 align="center" class="ofie">Find out what experts say about profiting from the cannabis market in 2021!</h2></a>
<h5 align="center" class="subheadline">Read our FREE 2021 cannabis outlook report!</h5>
<div align="center"><a class="button red radius" href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing"> Give me my free report! </a></div>
</div>
<!-- end large-8 -->
</div></div>
Keep reading...
Show less
Aurora Cannabis Closes Previously Announced Bought Deal Financing Over-Allotment Option Exercised in Full
January 26 | 2021
NYSE | TSX: ACB
Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000 . The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.
<div id="DivAssetPlaceHolder1">
<p> <a href="https://mma.prnewswire.com/media/1427050/Aurora_Cannabis_Inc__Aurora_Cannabis_Closes_Previously_Announced.html" rel="nofollow noopener noreferrer" target="_blank"> <img alt="Aurora Cannabis Inc. Logo (CNW Group/Aurora Cannabis Inc.)" class="lazy" data-src="https://mma.prnewswire.com/media/1427050/Aurora_Cannabis_Inc__Aurora_Cannabis_Closes_Previously_Announced.jpg" data-srcset="" src="https://mma.prnewswire.com/media/1427050/Aurora_Cannabis_Inc__Aurora_Cannabis_Closes_Previously_Announced.jpg" srcset="" title="Aurora Cannabis Inc. Logo (CNW Group/Aurora Cannabis Inc.)"/></a> </p>
</div>
<p> Each Unit is comprised of one common share of the Company (a “Common Share”) and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a “Warrant”). Each Warrant is exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of 36 months following the closing date of the Offering at an exercise price of <span> US$12.60 </span> per Warrant Share, subject to adjustment in certain events. </p>
<p> BMO Capital Markets and ATB Capital Markets acted as the bookrunners for the Offering. </p>
<p> The Company plans to use the net proceeds of the Offering for general corporate purposes, which may include opportunistically reducing debt. The Company believes that the Offering fits with its broader strategy to have a strong balance sheet while maintaining maximum flexibility to invest and build towards being a leader in global cannabinoids. </p>
<p> In connection with the Offering, the Company filed a prospectus supplement (the “Prospectus Supplement”) to the Company’s short form base shelf prospectus dated <span> October 28, 2020 </span> (the “Base Shelf Prospectus”) with the securities commissions or similar securities regulatory authorities in each of the provinces of <span> Canada </span> , except <span> Quebec </span> , and with the U.S. Securities and Exchange Commission (the “SEC”) as part of the Company’s registration statement on Form F-10 (the “Registration Statement”) under the U.S./Canada Multijurisdictional Disclosure System. The Prospectus Supplement, the Base Shelf Prospectus and the Registration Statement contain important detailed information about the Company and the Offering. </p>
<p> Copies of the Prospectus Supplement and the Base Shelf Prospectus are available on SEDAR at <a href="https://c212.net/c/link/?t=0&l=en&o=3047853-1&h=4222758636&u=http%3A%2F%2Fwww.sedar.com%2F&a=www.sedar.com" rel="nofollow noopener noreferrer" target="_blank"> www.sedar.com </a> and copies of the Prospectus Supplement and the Registration Statement are available on EDGAR at <a href="https://c212.net/c/link/?t=0&l=en&o=3047853-1&h=1445826938&u=http%3A%2F%2Fwww.sec.gov%2F&a=www.sec.gov" rel="nofollow noopener noreferrer" target="_blank"> www.sec.gov </a> . Copies of the Prospectus Supplement, the Base Shelf Prospectus and the Registration Statement may also be obtained from BMO Capital Markets by contacting BMO Capital Markets, Brampton Distribution Centre C/O The Data Group of Companies, 9195 Torbram Road, <span> Brampton, Ontario </span> , L6S 6H2 or by telephone at (905) 791-3151 Ext 431 or by email at <a href="mailto:torbramwarehouse@datagroup.ca" rel="nofollow noopener noreferrer" target="_blank"> torbramwarehouse@datagroup.ca </a> or from BMO Capital Markets Corp., Attn: Equity Syndicate Department, 3 Times Square, 25th Floor, <span> New York, NY </span> 10036 (Attn: Equity Syndicate), or by telephone at (800) 414-3627 or by email at <a href="mailto:bmoprospectus@bmo.com" rel="nofollow noopener noreferrer" target="_blank"> bmoprospectus@bmo.com </a> . Copies of such documents may also be obtained from ATB Capital Markets Inc., Attn: <span> Gail O’Connor </span> , 410-585 8th Ave SW, <span> Calgary, Alberta </span> , T2P 1G1, (403) 539-8629 or by email from <a href="mailto:atbcm_dealflow@atb.com" rel="nofollow noopener noreferrer" target="_blank"> atbcm_dealflow@atb.com </a> . </p>
<p> No securities regulatory authority has either approved or disapproved of the contents of this press release. This press release is for information purposes only and shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. </p>
<p> <b> About Aurora </b> </p>
<p> Aurora is a global leader in the cannabis industry serving both the medical and consumer markets. Headquartered in <span> Edmonton, Alberta </span> , Aurora is a pioneer in global cannabis dedicated to helping people improve their lives. The Company’s brand portfolio includes Aurora, Aurora Drift, San Rafael ’71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, and Reliva CBD. Providing customers with innovative, high-quality cannabis products, Aurora’s brands continue to break through as industry leaders in the medical, performance, wellness and recreational markets wherever they are launched. For more information, please visit our website at <a href="https://c212.net/c/link/?t=0&l=en&o=3047853-1&h=3531669935&u=http%3A%2F%2Fwww.auroramj.com%2F&a=www.auroramj.com" rel="nofollow noopener noreferrer" target="_blank"> www.auroramj.com </a> . </p>
<p> Aurora’s common shares trade on the TSX and NYSE under the symbol “ACB”, and is a constituent of the S&P/TSX Composite Index. </p>
<p> <b> Forward Looking Statements </b> </p>
<p> This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (” <b> forward-looking statements </b> “). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. Forward-looking statements made in this news release include statements regarding the expected use of proceeds of the Offering. These forward-looking statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward looking statements are based on the opinions, estimates and assumptions of management in light of management’s experience and perception of historical trends, current conditions and expected developments at the date the statements are made, such as current and future market conditions, the ability to maintain SG&A costs in line with current expectations, the ability to achieve high margin revenues in the Canadian consumer market, the current and future regulatory environment and future approvals and permits. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements, including the risks associated with: entering the U.S. market, the ability to realize the anticipated benefits associated with the acquisition of Reliva, achievement of Aurora’s business transformation plan, general business and economic conditions, changes in laws and regulations, product demand, changes in prices of required commodities, competition, the effects of and responses to the COVID-19 pandemic and other risks, uncertainties and factors set out under the heading “Risk Factors” in the Company’s annual information form dated <span> September 24, 2020 </span> (the ” <b> AIF </b> “) and filed with Canadian securities regulators available on the Company’s issuer profile on SEDAR at <a href="http://www.sedar.com" rel="nofollow noopener noreferrer" target="_blank"> www.sedar.com </a> and filed with and available on the SEC’s website at <a href="https://c212.net/c/link/?t=0&l=en&o=3047853-1&h=1445826938&u=http%3A%2F%2Fwww.sec.gov%2F&a=www.sec.gov" rel="nofollow noopener noreferrer" target="_blank"> www.sec.gov </a> , any of which could cause the Company to change its use of proceeds from the Offering. The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law. </p>
<div id="DivAssetPlaceHolder2"> </div>
<p id="PURL"> <img alt="Cision" class="lazy" data-src="https://c212.net/c/img/favicon.png?sn=TO59570&sd=2021-01-26" data-srcset="" height="12" src="https://c212.net/c/img/favicon.png?sn=TO59570&sd=2021-01-26" srcset="" title="Cision" width="12"/> View original content to download multimedia: <a href="http://www.prnewswire.com/news-releases/aurora-cannabis-closes-previously-announced-bought-deal-financing-over-allotment-option-exercised-in-full-301215269.html" id="PRNURL" rel="nofollow noopener noreferrer" target="_blank"> http://www.prnewswire.com/news-releases/aurora-cannabis-closes-previously-announced-bought-deal-financing-over-allotment-option-exercised-in-full-301215269.html </a> </p>
<p> SOURCE Aurora Cannabis Inc. </p>
</div>
<p> <img alt="" class="lazy" data-src="https://rt.prnewswire.com/rt.gif?NewsItemId=TO59570&Transmission_Id=202101261006PR_NEWS_USPR_____TO59570&DateId=20210126" data-srcset="" src="https://rt.prnewswire.com/rt.gif?NewsItemId=TO59570&Transmission_Id=202101261006PR_NEWS_USPR_____TO59570&DateId=20210126" srcset=""/></p></div>
<p>News Provided by PR Newswire via QuoteMedia</p>
<p></p><div class="cp-text-ad"><div class="row text-ad-ofie">
<div class="ad-image large-4 medium-4 small-12 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<img alt="Cannabis Free Report Cover" class="hide-for-small-only" src="https://cdn.investingnews.com/app/uploads/2020/05/Profiting-from-Cannabis-Industry-3D.jpg" title="Profiting from the Cannabis Industry"/></a></div>
<div class="ad-copy large-8 medium-8 small-11 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<h2 align="center" class="ofie">Find out what experts say about profiting from the cannabis market in 2021!</h2></a>
<h5 align="center" class="subheadline">Read our FREE 2021 cannabis outlook report!</h5>
<div align="center"><a class="button red radius" href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing"> Give me my free report! </a></div>
</div>
<!-- end large-8 -->
</div></div>
Keep reading...
Show less
Aurora Cannabis Closes Previously Announced Bought Deal Financing
January 26 | 2021
Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000. The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.
Each Unit is comprised of one common share of the Company (a “Common Share”) and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a “Warrant”). Each Warrant is exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of 36 months following the closing date of the Offering at an exercise price of US$12.60 per Warrant Share, subject to adjustment in certain events.
<p align="justify"> BMO Capital Markets and ATB Capital Markets acted as the bookrunners for the Offering. </p>
<p align="justify"> The Company plans to use the net proceeds of the Offering for general corporate purposes, which may include opportunistically reducing debt. The Company believes that the Offering fits with its broader strategy to have a strong balance sheet while maintaining maximum flexibility to invest and build towards being a leader in global cannabinoids. </p>
<p align="justify"> In connection with the Offering, the Company filed a prospectus supplement (the “Prospectus Supplement”) to the Company’s short form base shelf prospectus dated October 28, 2020 (the “Base Shelf Prospectus”) with the securities commissions or similar securities regulatory authorities in each of the provinces of Canada, except Quebec, and with the U.S. Securities and Exchange Commission (the “SEC”) as part of the Company’s registration statement on Form F-10 (the “Registration Statement”) under the U.S./Canada Multijurisdictional Disclosure System. The Prospectus Supplement, the Base Shelf Prospectus and the Registration Statement contain important detailed information about the Company and the Offering. </p>
<p align="justify"> Copies of the Prospectus Supplement and the Base Shelf Prospectus are available on SEDAR at <a href="https://www.globenewswire.com/Tracker?data=MAdDoaYbLKkct84tH19idRo4SCta84U9QSIpjssu3-Sp9cV5gpVB7RnoNSlVWwWIL-68aIvKKXAAi_HUYPVEmw==" rel="nofollow noopener noreferrer" target="_blank"> www.sedar.com </a> and copies of the Prospectus Supplement and the Registration Statement are available on EDGAR at <a href="https://www.globenewswire.com/Tracker?data=MAdDoaYbLKkct84tH19idTJikgRFCAspdQ2wW1IwkEacYULG-vDaoIr7JHJz3X4xqmOCwveMf4PPotY6bOCF5A==" rel="nofollow noopener noreferrer" target="_blank"> www.sec.gov </a> . Copies of the Prospectus Supplement, the Base Shelf Prospectus and the Registration Statement may also be obtained from BMO Capital Markets by contacting BMO Capital Markets, Brampton Distribution Centre C/O The Data Group of Companies, 9195 Torbram Road, Brampton, Ontario, L6S 6H2 or by telephone at (905) 791-3151 Ext 431 or by email at <a href="https://www.globenewswire.com/Tracker?data=Qer2ViXkZWn-wgzZ91E6S01Oqdw-BMjrxPtjPiIvmukeM2GoCOQp2vQTt-z9P4tk7ntIkXehu4Oy8CyjsyVipnKGJ75zTPzmdDpr2ldcm15nySq6EguajRhHdC6tBBiE" rel="nofollow noopener noreferrer" target="_blank"> torbramwarehouse@datagroup.ca </a> or from BMO Capital Markets Corp., Attn: Equity Syndicate Department, 3 Times Square, 25th Floor, New York, NY 10036 (Attn: Equity Syndicate), or by telephone at (800) 414-3627 or by email at <a href="https://www.globenewswire.com/Tracker?data=z_CMtijRRKBm5Xy4fUrRuFzEGSJZzs089J4JiqITAjP08U7t0fBFOMYKH3fipl-84qx99ISKbsIAqpXz1wZJiEDwsAQwJE89OxaWI3lJvfQ=" rel="nofollow noopener noreferrer" target="_blank"> bmoprospectus@bmo.com </a> . Copies of such documents may also be obtained from ATB Capital Markets Inc., Attn: Gail O’Connor, 410-585 8th Ave SW, Calgary, Alberta, T2P 1G1, (403) 539-8629 or by email from <a href="https://www.globenewswire.com/Tracker?data=MVZ2VUwkYalWYkgBE9IikzzDECh5TNPiGqeCPjAyZPEo2-2BRLszY8p9CWnxumVG9LLOHP0l_dVHZJKz7icuxOtv-hByv8kBBzBC5Rw00UA=" rel="nofollow noopener noreferrer" target="_blank"> atbcm_dealflow@atb.com </a> . </p>
<p align="justify"> No securities regulatory authority has either approved or disapproved of the contents of this press release. This press release is for information purposes only and shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. </p>
<p align="justify"> <strong> About Aurora </strong> </p>
<p align="justify"> Aurora is a global leader in the cannabis industry serving both the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis dedicated to helping people improve their lives. The Company’s brand portfolio includes Aurora, Aurora Drift, San Rafael ‘71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, and Reliva CBD. Providing customers with innovative, high-quality cannabis products, Aurora’s brands continue to break through as industry leaders in the medical, performance, wellness and recreational markets wherever they are launched. For more information, please visit our website at <a href="https://www.globenewswire.com/Tracker?data=6BXx2QgQ63hn9uY4Rh2UlMf2xwYwLV0buVxUTId_JQ7hKQluu-9k6gzel68cZxCqS1FCYN4-tclkzdKuDVqfXQ==" rel="nofollow noopener noreferrer" target="_blank"> www.auroramj.com </a> . </p>
<p align="justify"> Aurora’s common shares trade on the TSX and NYSE under the symbol “ACB”, and is a constituent of the S&P/TSX Composite Index. </p>
<div>
<table><tbody><tr><td> <strong> Further Information </strong> </td>
<td> </td>
</tr><tr><td> </td>
<td> </td>
</tr><tr><td> <strong> For Media: </strong> </td>
<td> <strong> For Investors: </strong> </td>
</tr><tr><td> </td>
<td> </td>
</tr><tr><td> Michelle Lefler </td>
<td> ICR, Inc. </td>
</tr><tr><td> VP, Communications & PR </td>
<td> Investor Relations </td>
</tr><tr><td> media@auroramj.com </td>
<td> aurora@icrinc.com </td>
</tr></tbody></table></div>
<p align="justify"> <strong> Forward Looking Statements </strong> </p>
<p align="justify"> This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (” <strong> forward-looking statements </strong> “). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. Forward-looking statements made in this news release include statements regarding the expected use of proceeds of the Offering. These forward-looking statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward looking statements are based on the opinions, estimates and assumptions of management in light of management’s experience and perception of historical trends, current conditions and expected developments at the date the statements are made, such as current and future market conditions, the ability to maintain SG&A costs in line with current expectations, the ability to achieve high margin revenues in the Canadian consumer market, the current and future regulatory environment and future approvals and permits. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements, including the risks associated with: entering the U.S. market, the ability to realize the anticipated benefits associated with the acquisition of Reliva, achievement of Aurora’s business transformation plan, general business and economic conditions, changes in laws and regulations, product demand, changes in prices of required commodities, competition, the effects of and responses to the COVID-19 pandemic and other risks, uncertainties and factors set out under the heading “Risk Factors” in the Company’s annual information form dated September 24, 2020 (the “ <strong> AIF </strong> ”) and filed with Canadian securities regulators available on the Company’s issuer profile on SEDAR at www.sedar.com and filed with and available on the SEC’s website at www.sec.gov, any of which could cause the Company to change its use of proceeds from the Offering. The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law. </p>
<p> <img class="lazy" data-src="https://www.globenewswire.com/newsroom/ti?nf=ODE0MTg3MCMzOTQ1NjIzIzUwMDA3NTU1MA==" data-srcset="" height="1" src="https://www.globenewswire.com/newsroom/ti?nf=ODE0MTg3MCMzOTQ1NjIzIzUwMDA3NTU1MA==" srcset="" width="1"/><br/><img class="lazy" data-src="https://ml.globenewswire.com/release/track/85551247-1b34-4807-b99b-de21c55daba4" data-srcset="" height="1" referrerpolicy="no-referrer-when-downgrade" src="https://ml.globenewswire.com/release/track/85551247-1b34-4807-b99b-de21c55daba4" srcset="" width="1"/></p>
<p> <a href="https://www.globenewswire.com/NewsRoom/AttachmentNg/2f7c804e-402d-4be8-98a6-ea33ef6fce4b" rel="noopener noreferrer" target="_blank"> <img alt="Primary Logo" border="0" class="lazy" data-src="https://ml.globenewswire.com/media/2f7c804e-402d-4be8-98a6-ea33ef6fce4b/small/acb-jpg.jpg" data-srcset="" height="39" src="https://ml.globenewswire.com/media/2f7c804e-402d-4be8-98a6-ea33ef6fce4b/small/acb-jpg.jpg" srcset="" width="150"/></a> </p>
</div>
<p>News Provided by GlobeNewswire via QuoteMedia</p>
<p></p><div class="cp-text-ad"><div class="row text-ad-ofie">
<div class="ad-image large-4 medium-4 small-12 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<img alt="Cannabis Free Report Cover" class="hide-for-small-only" src="https://cdn.investingnews.com/app/uploads/2020/05/Profiting-from-Cannabis-Industry-3D.jpg" title="Profiting from the Cannabis Industry"/></a></div>
<div class="ad-copy large-8 medium-8 small-11 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<h2 align="center" class="ofie">Find out what experts say about profiting from the cannabis market in 2021!</h2></a>
<h5 align="center" class="subheadline">Read our FREE 2021 cannabis outlook report!</h5>
<div align="center"><a class="button red radius" href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing"> Give me my free report! </a></div>
</div>
<!-- end large-8 -->
</div></div>
Keep reading...
Show less
AMP German Cannabis Group Inc. (” AMP “) (CSE: XCX ), ( Frankfurt : C4T ) (ISIN: CA00176G1028) and Aphria Inc.’s (” Aphria “) (TSX: APHA ) (NASDAQ: APHA) wholly-owned German subsidiary, CC Pharma GmbH (” CC Pharma “), have entered into a strategic agreement (the ” Co-Promotion Agreement “) covering joint marketing of sales for Aphria brand medical cannabis products for the German market.
The Co-Promotion Agreement is a collaboration contract between AMP and CC Pharma to sell the Aphria medical cannabis brand in Germany . In addition, AMP will organize with the support of CC Pharma, “information events” in Germany to market Aphria branded products to doctors and pharmacists.
<p> <span> Hendrik Knopp </span> , Managing Director of Aphria Germany GmbH mentioned, “We are proud to launch our high-quality medical cannabis under the Aphria brand in <span> Germany </span> with the support of AMP. This agreement provides the opportunity to expand the Aphria brand in <span> Germany </span> , one of our key international markets.” </p>
<p> Dr. <span> Stefan Feuerstein </span> , Director and President of AMP, commented, “We are proud to partner with Aphria and CC Pharma GmbH. Our sole focus is to sell medical cannabis in <span> Germany </span> , which makes us an ideal partner to co-promote and sell the Aphria brand. In preparation for this partnership, we have significantly expanded our sales team to sell the Aphria and AMP brands as well as other branded medical cannabis products across <span> Germany </span> .” </p>
<p> <b> About Aphria Inc. <br/></b> </p>
<p> Aphria Inc. is a leading global cannabis-lifestyle consumer packaged goods company with operations in <span> Canada </span> , <span> United States </span> , <span> Europe </span> , and <span> Latin America </span> , that is changing people’s lives for the better – one person at a time – by inspiring and empowering the worldwide community to live their very best life by providing them with products that meet the needs of their mind, body and soul and invoke a sense of wellbeing. Aphria’s mission is to be the trusted partner for its patients and consumers by providing them with a cultivated experience and health and wellbeing through high-quality, differentiated brands and innovative products. </p>
<p> Headquartered in <span> Leamington, Ontario </span> , Aphria cultivates, processes, markets and sells medical and adult-use cannabis, cannabis-derived extracts and derivative cannabis products in <span> Canada </span> under the provisions of the Cannabis Act and globally pursuant to applicable international regulations. Aphria also manufactures, markets and sells alcoholic beverages in <span> the United States </span> . For more information, please visit: <a href="https://c212.net/c/link/?t=0&l=en&o=3047413-2&h=3511329287&u=https%3A%2F%2Faphria.ca%2F&a=https%3A%2F%2Faphria.ca" rel="nofollow noopener noreferrer" target="_blank"> https://aphria.ca </a> . </p>
<p> <b> About CC Pharma GmbH </b> </p>
<p> Founded in 1999, CC Pharma is based in Densborn, <span> Germany </span> and is one of the leading national distributors of pharmaceutical products to pharmacists in <span> Germany </span> , with over 13,000 pharmacies in its sales network. For more information, please visit: <a href="https://c212.net/c/link/?t=0&l=en&o=3047413-2&h=3757726379&u=http%3A%2F%2Fwww.cc-pharma.de%2F&a=www.cc-pharma.de" rel="nofollow noopener noreferrer" target="_blank"> www.cc-pharma.de </a> . </p>
<p> <b> About AMP German Cannabis Group </b> </p>
<p> AMP German Cannabis Group is licensed to import European Union – Good Manufacturing Practice (EU-GMP) medical cannabis from <span> Europe </span> and elsewhere into <span> Germany </span> . AMP sources, stores, transports, delivers, and sells medical cannabis products to pharmaceutical distributors or pharmacists directly, the only point-of-sale for medical cannabis to German patients with a physician’s prescription. AMP has entered into a non-exclusive distribution agreement for medical cannabis with a leading distributor of pharmaceuticals products to more than 13,000 pharmacies throughout <span> Germany </span> . </p>
<p> AMP has sponsored a six-episode roundtable discussion series about medical cannabis in <span> Germany </span> . The Roundtable Series is available by podcast or video. In Episode #2 titled, “Politics and Medical Cannabis in <span> Germany </span> “, Dr. Wieland Schinnenburg, MdB (FDP) provides an up-to-date overview of the political issues and challenges facing the medical cannabis industry in <span> Germany </span> . The panel also includes Dr. <span> Stefan Feuerstein </span> , President of AMP and Mr. <span> Holger Scholze </span> as moderator. AMP Roundtable Series: <a href="https://c212.net/c/link/?t=0&l=en&o=3047413-2&h=871145971&u=http%3A%2F%2Fwww.amp-eu.de%2Froundtable&a=www.amp-eu.de%2Froundtable" rel="nofollow noopener noreferrer" target="_blank"> www.amp-eu.de/roundtable </a> </p>
<p> For more information, please visit: <a href="https://c212.net/c/link/?t=0&l=en&o=3047413-2&h=877455811&u=http%3A%2F%2Fwww.amp-eu.com%2F&a=www.amp-eu.com" rel="nofollow noopener noreferrer" target="_blank"> www.amp-eu.com </a> </p>
<p> Aphria Inc. social media links: </p>
<ul type="disc"><li> Twitter: <a href="https://c212.net/c/link/?t=0&l=en&o=3047413-2&h=125661343&u=https%3A%2F%2Ftwitter.com%2Faphriainc&a=https%3A%2F%2Ftwitter.com%2Faphriainc" rel="nofollow noopener noreferrer" target="_blank"> https://twitter.com/aphriainc </a> </li>
<li> LinkedIn: <a href="https://c212.net/c/link/?t=0&l=en&o=3047413-2&h=2600492256&u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Faphriainc%2F&a=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Faphriainc" rel="nofollow noopener noreferrer" target="_blank"> https://www.linkedin.com/company/aphriainc </a> </li>
<li> Facebook: <a href="https://c212.net/c/link/?t=0&l=en&o=3047413-2&h=2874999087&u=https%3A%2F%2Fwww.facebook.com%2FaphriaMMJ%2F&a=https%3A%2F%2Fwww.facebook.com%2FaphriaMMJ" rel="nofollow noopener noreferrer" target="_blank"> https://www.facebook.com/aphriaMMJ </a> </li>
</ul><p> AMP social media links: </p>
<ul type="disc"><li> Twitter: <a href="https://c212.net/c/link/?t=0&l=en&o=3047413-2&h=3536183099&u=https%3A%2F%2Ftwitter.com%2FAMP_Cannabis&a=https%3A%2F%2Ftwitter.com%2FAMP_Cannabis" rel="nofollow noopener noreferrer" target="_blank"> https://twitter.com/AMP_Cannabis </a> </li>
<li> LinkedIn: <a href="https://c212.net/c/link/?t=0&l=en&o=3047413-2&h=3586621182&u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fampgermancannabisgroup&a=www.linkedin.com%2Fcompany%2Fampgermancannabisgroup" rel="nofollow noopener noreferrer" target="_blank"> www.linkedin.com/company/ampgermancannabisgroup </a> </li>
<li> Facebook: <a href="https://c212.net/c/link/?t=0&l=en&o=3047413-2&h=1607904271&u=http%3A%2F%2Fwww.facebook.com%2FAMPGCG&a=www.facebook.com%2FAMPGCG" rel="nofollow noopener noreferrer" target="_blank"> www.facebook.com/AMPGCG </a> </li>
<li> Instagram: <a href="https://c212.net/c/link/?t=0&l=en&o=3047413-2&h=4031280463&u=http%3A%2F%2Fwww.instagram.com%2Fampgcg&a=www.instagram.com%2Fampgcg" rel="nofollow noopener noreferrer" target="_blank"> www.instagram.com/ampgcg </a> </li>
<li> Podcast: <a href="https://c212.net/c/link/?t=0&l=en&o=3047413-2&h=547854690&u=http%3A%2F%2Fow.ly%2FEqBc50BJ4xw&a=http%3A%2F%2Fow.ly%2FEqBc50BJ4xw" rel="nofollow noopener noreferrer" target="_blank"> http://ow.ly/EqBc50BJ4xw </a> </li>
</ul><p> Media Kit: <a href="https://c212.net/c/link/?t=0&l=en&o=3047413-2&h=2409294714&u=http%3A%2F%2Fwww.amp-eu.com%2Fmedia-kit&a=www.amp-eu.com%2Fmedia-kit" rel="nofollow noopener noreferrer" target="_blank"> www.amp-eu.com/media-kit </a> </p>
<p> CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information in this news release constitutes forward-looking information or forward-looking statements (together, “forward-looking statements”) under applicable securities laws and are expressly qualified by this cautionary statement. Any information or statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements, including, but not limited to, statements in this news release with regards to the expected impact of the EU GMP certification on the Company’s business and expectations related to the Company’s market position. The Company uses words such as “forecast”, “future”, “should”, “could”, “enable”, “potential”, “contemplate”, “believe”, “anticipate”, “estimate”, “plan”, “expect”, “intend”, “may”, “project”, “will”, “would” and the negative of these terms or similar expressions to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Various assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this news release. Forward-looking statements reflect management’s current beliefs with respect to future events and are based on information currently available to management including based on reasonable assumptions, estimates, internal and external analysis and opinions of management considering its experience, perception of trends, current conditions and expected developments as well as other factors that management believes to be relevant as at the date such statements are made. Forward-looking statements involve significant known and unknown risks and uncertainties. Many factors could cause actual results, performance or achievement to be materially different from any future forward-looking statements. Factors that may cause such differences include, but are not limited to, risks associated with COVID-19 nationally and globally which could have a material adverse impact on Aphria’s business, operations and financial results, including disruptions in the supply chains and sales channels, as well as a deterioration of general economic conditions including national and/or global recessions and the response of governments to the COVID-19 pandemic in respect of the operation of retail stores; general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving cannabis or otherwise affecting Aphria’s business or its consumers generally; inability to access sufficient capital from internal and external sources; income tax and regulatory matters, including delays in the issuance of licenses; the sale and distribution of vapes; the ability of Aphria to meet its liquidity requirements to fund ongoing operations; the ability of Aphria to implement its business strategies; competition; currency and interest rate fluctuations. </p>
<p> Readers are cautioned that the foregoing list is not exhaustive and should carefully review the various risks and uncertainties identified in the Company’s filings on SEDAR and EDGAR. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. </p>
<p> The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities laws. Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release. In addition, neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. </p>
<p> Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. </p>
<div id="DivAssetPlaceHolder5790">
<p> <a href="https://mma.prnewswire.com/media/1426703/AMP_German_Cannabis_Group_Inc.html" rel="nofollow noopener noreferrer" target="_blank"> <img alt="AMP German Cannabis Group Inc. Logo (CNW Group/AMP German Cannabis Group Inc.)" class="lazy" data-src="https://mma.prnewswire.com/media/1426703/AMP_German_Cannabis_Group_Inc.jpg" data-srcset="" src="https://mma.prnewswire.com/media/1426703/AMP_German_Cannabis_Group_Inc.jpg" srcset="" title="AMP German Cannabis Group Inc. Logo (CNW Group/AMP German Cannabis Group Inc.)"/></a> </p>
</div>
<div id="DivAssetPlaceHolder0">
<p> <a href="https://mma.prnewswire.com/media/1426702/Aphria_Inc_Logo.html" rel="nofollow noopener noreferrer" target="_blank"> <img alt="Aphria Inc. Logo (CNW Group/AMP German Cannabis Group Inc.)" class="lazy" data-src="https://mma.prnewswire.com/media/1426702/Aphria_Inc_Logo.jpg" data-srcset="" src="https://mma.prnewswire.com/media/1426702/Aphria_Inc_Logo.jpg" srcset="" title="Aphria Inc. Logo (CNW Group/AMP German Cannabis Group Inc.)"/></a> </p>
</div>
<p> SOURCE AMP German Cannabis Group Inc. </p>
<p> <img alt="" class="lazy" data-src="https://rt.newswire.ca/rt.gif?NewsItemId=C0266&Transmission_Id=202101260900CANADANWCANADAPR_C0266&DateId=20210126" data-srcset="" src="https://rt.newswire.ca/rt.gif?NewsItemId=C0266&Transmission_Id=202101260900CANADANWCANADAPR_C0266&DateId=20210126" srcset=""/></p>
<p> <img alt="Cision" class="lazy" data-src="https://c212.net/c/img/favicon.png?sn=C0266&sd=2021-01-26" data-srcset="" height="12" src="https://c212.net/c/img/favicon.png?sn=C0266&sd=2021-01-26" srcset="" title="Cision" width="12"/> View original content to download multimedia: <a href="http://www.newswire.ca/en/releases/archive/January2021/26/c0266.html" rel="noopener noreferrer" target="_blank"> http://www.newswire.ca/en/releases/archive/January2021/26/c0266.html </a> </p>
</div>
</div>
<p>News Provided by Canada Newswire via QuoteMedia</p>
<p></p><div class="cp-text-ad"><div class="row text-ad-ofie">
<div class="ad-image large-4 medium-4 small-12 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<img alt="Cannabis Free Report Cover" class="hide-for-small-only" src="https://cdn.investingnews.com/app/uploads/2020/05/Profiting-from-Cannabis-Industry-3D.jpg" title="Profiting from the Cannabis Industry"/></a></div>
<div class="ad-copy large-8 medium-8 small-11 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<h2 align="center" class="ofie">Find out what experts say about profiting from the cannabis market in 2021!</h2></a>
<h5 align="center" class="subheadline">Read our FREE 2021 cannabis outlook report!</h5>
<div align="center"><a class="button red radius" href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing"> Give me my free report! </a></div>
</div>
<!-- end large-8 -->
</div></div>
Keep reading...
Show less
HempFusion Wellness Inc. ( TSX:CBD.U ) ( FWB:8OO ) (“ HempFusion ” or the “ Company ”) is pleased to announce that it has been included in two leading cannabis & hemp-derived CBD focused exchange-traded funds (“ ETFs ”), AdvisorShares Pure US Cannabis ETF ( NYSE:MSOS ) and AdvisorShares Pure Cannabis ETF ( NYSE:YOLO ).
AdvisorShares is a leading sponsor of actively managed ETFs. Pure US Cannabis ETF (MSOS) is the only US-listed ETF dedicated solely to US cannabis exposure, with over US$616,000,000 in assets under management (“ AUM ”). Pure Cannabis ETF (YOLO) was the first US-based actively managed ETF focused on the global cannabis industry. YOLO and MSOS endeavor to achieve long-term capital growth by investing in some of the largest foreign and domestic cannabis and hemp-derived CBD companies. The two AdvisorShares ETFs have a combined AUM of over US$880,000,000 as of January 22, 2021.
<p> “We are pleased the AdvisorShares ETFs have initiated positions in our Company. This represents a strong milestone for the Company and provides us added exposure to the investment community,” commented Jason Mitchell, N.D., HempFusion’s co-founder and CEO. “Inclusion in these ETFs brings additional exposure to potential new investors as well as generates value for existing shareholders. With our listing on the TSX, current market capitalization, and liquidity, we believe we now meet many cannabis-related ETFs’ inclusion requirements, and we look forward to other potential ETFs’ initiating positions.” </p>
<p> <b> ABOUT HEMPFUSION </b> </p>
<p> HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research, and HF Labs, to approximately 4,000 retail locations across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 46 SKUs including tinctures, proprietary FDA Drug Listed Over-The-Counter (OTC) Topicals, Doctor/Practitioner Lines and more. With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion is a board member of the US Hemp Roundtable, and HempFusion’s wholly-owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex™ and are available in-store or by visiting HempFusion online at <a href="https://investingnews.com/company-profiles/hempfusion-wellness/" rel="nofollow noopener noreferrer" shape="rect" target="_blank"> www.hempfusion.com </a> or <a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.probulin.com&esheet=52367574&newsitemid=20210126005426&lan=en-US&anchor=www.probulin.com&index=4&md5=718fc95113af4d29a7cfb771c88d89cf" rel="nofollow noopener noreferrer" shape="rect" target="_blank"> www.probulin.com </a> . </p>
<p> Follow HempFusion on <a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Ftwitter.com%2Fhempfusion&esheet=52367574&newsitemid=20210126005426&lan=en-US&anchor=Twitter&index=5&md5=b528947695b294911e00393ec5b986b2" rel="nofollow noopener noreferrer" shape="rect" target="_blank"> Twitter </a> , <a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Ffacebook.com%2Fhempfusionproducts&esheet=52367574&newsitemid=20210126005426&lan=en-US&anchor=Facebook&index=6&md5=d28e51d6a81e41597713d25ee764f8cb" rel="nofollow noopener noreferrer" shape="rect" target="_blank"> Facebook </a> and <a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Finstagram.com%2Fhempfusion&esheet=52367574&newsitemid=20210126005426&lan=en-US&anchor=Instagram&index=7&md5=cf721953dfac8196eab9dce45858d0f7" rel="nofollow noopener noreferrer" shape="rect" target="_blank"> Instagram </a> and Probulin on <a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Ftwitter.com%2Fprobulin&esheet=52367574&newsitemid=20210126005426&lan=en-US&anchor=Twitter&index=8&md5=42082df60556f80f58d9cf60fb75c5a4" rel="nofollow noopener noreferrer" shape="rect" target="_blank"> Twitter </a> , <a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Ffacebook.com%2Fprobulin&esheet=52367574&newsitemid=20210126005426&lan=en-US&anchor=Facebook&index=9&md5=55249cb5f6e152e72897f8332e3ad476" rel="nofollow noopener noreferrer" shape="rect" target="_blank"> Facebook </a> and <a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Finstagram.com%2Fprobulin&esheet=52367574&newsitemid=20210126005426&lan=en-US&anchor=Instagram&index=10&md5=2bffccbccea77eb1313537a93b01a988" rel="nofollow noopener noreferrer" shape="rect" target="_blank"> Instagram </a> . </p>
<p> <b> FORWARD-LOOKING STATEMENTS </b> </p>
<p> This news release contains forward-looking statements and forward-looking information within the meaning of Canadian securities legislation (collectively, “ <b> forward-looking statements </b> “) that relate to HempFusion’s current expectations and views of future events. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, through the use of words or phrases such as “will likely result”, “are expected to”, “expects”, “will continue”, “is anticipated”, “anticipates”, “believes”, “estimated”, “intends”, “plans”, “forecast”, “projection”, “strategy”, “objective” and “outlook”) are not historical facts and may be forward-looking statements and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ materially from those expressed in such forward-looking statements. No assurance can be given that these expectations will prove to be correct and such forward-looking statements included in this news release should not be unduly relied upon. These statements speak only as of the date of this news release. In particular and without limitation, this news release contains forward-looking statements relating to meeting the inclusion requirements of or inclusion in other cannabis-related ETFs and the Company’s other plans, focus and objectives. </p>
<p> Forward-looking statements are based on a number of assumptions and are subject to a number of risks and uncertainties, many of which are beyond HempFusion’s control, which could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to, the impact and progression of the COVID-19 pandemic and other factors set forth under “ <i> Forward-Looking Statements </i> ” and “ <i> Risk Factors </i> ” in the final long form prospectus of the Company dated December 17, 2020 and available under the Company’s profile on SEDAR at <a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.sedar.com&esheet=52367574&newsitemid=20210126005426&lan=en-US&anchor=www.sedar.com&index=11&md5=345f80ae5f7ba509eb4f1d5d9e2741f2" rel="nofollow noopener noreferrer" shape="rect" target="_blank"> www.sedar.com </a> . HempFusion undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. New factors emerge from time to time, and it is not possible for HempFusion to predict all of them or assess the impact of each such factor or the extent to which any factor, or combination of factors, may cause results to differ materially from those contained in any forward-looking statement. Any forward-looking statements contained in this news release are expressly qualified in their entirety by this cautionary statement. </p>
<p> <b> Neither the TSX nor its Regulation Services Provider (as that term is defined in the policies of the TSX) accepts responsibility for the adequacy or accuracy of this release. </b> </p>
<p> <img alt="" class="lazy" data-src="https://cts.businesswire.com/ct/CT?id=bwnews&sty=20210126005426r1&sid=quot2&distro=nx&lang=en" data-srcset="" src="https://cts.businesswire.com/ct/CT?id=bwnews&sty=20210126005426r1&sid=quot2&distro=nx&lang=en" srcset=""/><span></span> </p>
<p id="mmgallerylink"> <span id="mmgallerylink-phrase"> View source version on businesswire.com: </span> <span id="mmgallerylink-link"> <a href="https://www.businesswire.com/news/home/20210126005426/en/" rel="nofollow noopener noreferrer" target="_blank"> https://www.businesswire.com/news/home/20210126005426/en/ </a> </span> </p>
<p> Jason Mitchell, N.D. <br/> Chief Executive Officer and Director <br/> Email: <a href="mailto:ir@hempfusion.com" rel="nofollow noopener noreferrer" shape="rect" target="_blank"> ir@hempfusion.com </a> <br/> Phone: 416-803-5638 </p>
</div>
<p>News Provided by Business Wire via QuoteMedia</p>
<p></p><div class="stock-information sidebar-block">
<div class="title">Request an Investor Kit: <h3>HempFusion Wellness</h3></div>
<form action="https://investingnews.com" id="subscribe_per_category" method="POST">
<div class="form-column left">
<input name="profiles_only" type="hidden" value="yes"/><input name="subscription_form" type="hidden" value="yes"/><input name="subscribe_company_profile_form" type="hidden" value="1"/><input name="source" type="hidden" value="https://investingnews.com/news/biotech-investing/hempfusion-announces-inclusion-in-leading-cannabis-etfs/"/><input class="referrer" name="referral_url" type="hidden" value=""/><input name="form_name" type="hidden" value="subscribe_cprofile_use_posts"/><input class="referrer" name="referral_url" type="hidden" value=""/><input name="cprofiles[]" type="hidden" value="Tzo4OiJzdGRDbGFzcyI6NDp7czoyOiJpZCI7czozNjoiMWIyNjFjMDUtNTc0My01MzkxLWE5ZTgtNWZiNmZhZWIwZTEzIjtzOjQ6Im5hbWUiO3M6MTk6IkhlbXBGdXNpb24gV2VsbG5lc3MiO3M6NDoid3BpZCI7czo5OiIxMDE2MTA2OTIiO3M6MzoidXJsIjtzOjA6IiI7fQ=="/><input class="form-control" id="FirstName" name="first_name" placeholder="First Name" required="" type="text" value=""/><input class="form-control" id="LastName" name="last_name" placeholder="Last Name" required="" type="text" value=""/><input class="form-control" id="email" name="email" placeholder="Email" required="" type="email" value=""/><input class="form-control" id="phone" name="user_phone" pattern="[\+\s0-9]{3,15}" placeholder="Phone" title="Telephone number. Only digits and space signs are allowed" type="tel" value=""/></div>
<input class="g-recaptcha-response" id="g-recaptcha-response_5170" name="g-recaptcha-response" type="hidden"/><input class="value_recaptcha" name="action" type="hidden" value="validate_captcha_5170"/><div class="form-column right">
<div class="extra-input">
<input id="AccreditedInvestor" name="accredited_investor" type="checkbox"/><label class="checkbox-label" for="AccreditedInvestor">
Include me in the <b>Accredited Investor</b> email list
<span class="help">
<i aria-hidden="true" class="fa fa-question-circle"></i>
<div class="help-box bigger">
Some investment opportunities are limited to accredited investors. Whether you are an accredited investor or not depends on where you live and other criteria. For full details go to https://investingnews.com/accredited-investor-definition/ or search for "accredited investor" in the search bar above.
</div>
</span>
</label>
</div>
<div class="more">
<input class="btn btn-primary" type="submit" value="Get More information"/></div>
<p class="legend">By completing this form, you are giving consent to receive communication from HempFusion Wellness using the contact information you provide. And remember you can unsubscribe at any time.</p>
</div>
</form>
</div>
Keep reading...
Show less